By MICHAEL J. de la MERCED
Mr. Gosebruch, 42, who was promoted in March to co-head of North American mergers, has been one of the bank’s top deal makers for the pharmaceutical industry.
Published: September 17, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1QH14St
from WordPress http://ift.tt/1P05vXj
via Hadi Aboukhater
No comments:
Post a Comment